Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Early-stage Lung Cancer by Using Methylation Signatures in Circulating Tumor DNA

NCT03685669 is registered in ClinicalTrials.gov with Shanghai Chest Hospital as lead sponsor.

NCT NCT03685669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03685669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Early-stage Lung Cancer by Using Methylation Signatures in Circulating Tumor DNA
Lead sponsor
Shanghai Chest Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2017
Completion date
December 31, 2019
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung nodule